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Abstract
Background: Experimental evidences suggest an increased collagen deposition in inflammatory
bowel diseases (IBD). In particular, large amounts of collagen type I, III and V have been described
and correlated to the development of intestinal fibrotic lesions. No information has been available
until now  about the possible increased collagen deposition far from the main target organ. In the
hypothesis that chronic inflammation and increased collagen metabolism are reflected also in the
systemic circulation, we aimed this study to evaluate the effects on left ventricular wall structure
by assessing splancnic and systemic collagen metabolism (procollagen III assay), deposition
(ultrasonic tissue characterization), and cardiac function (echocardiography) in patients with
different long standing history of IBD, before and after surgery.
Methods: Thirty patients affected by active IBD, 15 with Crohn and 15 with Ulcerative Colitis,
submitted to surgery will be enrolled in the study in a double blind fashion. They will be studied
before the surgical operation and 6, 12 months after surgery. A control group of 15 healthy age
and gender-matched subjects will also be studied. At each interval blood samples will be collected
in order to assess the collagen metabolism; a transthoracic echocardiogram will be recorded for
the subsequent determination of cardiac function and collagen deposition.
Discussion: From this study protocol we expect additional information about the association
between IBD and cardiovascular disorders; in particular to address the question if chronic
inflammation, through the altered collagen metabolism, could affect left ventricular structure and
function in a manner directly related to the estimated duration of the disease.
Background
Crohn's disease and ulcerative colitis are chronic inflam-
matory bowel diseases (IBD) of unknown origin and
pathogenesis of adolescent and young adulthood, with
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peak incidence occurring between 15 and 30 years; ap-
proximately 25% of patients are diagnosed during the first
two decades of life. These conditions are characterized by
focal or diffuse inflammation of the alimentary tract [1–
4]. The chronic inflammatory status and the need of a
longstanding therapy expose the patient to several extrain-
testinal manifestations. Cardiovascular ones are not rare
findings and include autoimmune manifestations such as
Takayasu's arteritis [5,6], pericarditis, myocardiopericar-
ditis [7], drug-induced effects such as steroid-hyperten-
sion [8], pericarditis related to long-standing mesalazine
treatment [9], thrombosis of the deep veins of the legs,
and pulmonary embolism [10]. Chronic inflammation is
also associated with an increase in collagen deposition to
the main target organ; in particular the development of in-
testinal fibrotic lesions containing large amounts of colla-
gen type I, III and V has been described [11,12]. Until now
to our knowledge no reports are available in literature
about the possible increased collagen deposition far from
the main target organ in IBD. However, the cardiac in-
volvement during inflammatory diseases such as systemic
lupus erythematosus (13), systemic sclerosis (14), anky-
losing spondylitis (15), and rheumathoid arthritis (16)
has been described and ascribed to myocardial fibrosis.
This perspective study has the objective to determine the
effects of chronic inflammation on left ventricular wall by
assessing collagen metabolism, deposition, and cardiac
function in patients with different long standing history of
IBD, before and after surgery.
Methods/Design
Two teams will participate to the study: General Surgeons
and Cardiologists. All data will be recorded in a database.
Study population
Thirty patients affected by active IBD, 15 with Crohn and
15 with Ulcerative Colitis, submitted to surgery will be en-
rolled in the study in a double blind fashion; they will be
studied before the surgical operation and 6, 12 months af-
ter surgery. Disease activity will be assessed according to
the Crohn's Disease Activity Index (17) and the Truelove-
Witts index (18) for Crohn and ulcerative colitis, respec-
tively. A control group of 15 healty age and gender-
matched subjects will be also studied. At each interval
blood samples will be collected in order to assess the col-
lagen metabolism; a transthoracic echocardiogram will be
recorded for the subsequent determination of cardiac
function and collagen deposition.
Collagen metabolism (PIIIP)
Different kinds of collagens have been identified in hu-
mans; all of them derive from longer precursor molecules
(procollagens), that are synthesized intracellulary and se-
creted in extracellular space where they are cleaved by
aminoproteases [19,20]. Among the different kinds of
precursors, type III is one of the most abundant interstitial
procollagens in myocardium. Since its aminoterminal
propeptide (PIIIP) is formed in equimolar proportions to
collagen, serum measurements of this fragment can pro-
vide an index of collagen synthesis, also during acromeg-
aly [21]. Concerning IBD, other Authors have described
changes in PIIIP in patients with active Crohn's disease,
before and after specific medical therapy [11,12].
At baseline after an overnight fast, before surgery (system-
ic PIIIP) and during surgery (splancnic PIIIP), serum lev-
els of PIIIP will be assessed by commercial
radioimmunoassay (Orion Diagnostics, Finland) which
sensibility, intra-assay variation and inter-assay variation
are respectively: 2,6 mcg/l, 4,0% and 4,3%. Normal rang-
es of PIIIP concentrations are 3,1  1,1 mg/l. Following
the same procedure, blood samples will be collected dur-
ing the follow-up, to assess serum PIIIP concentrations 6
and 12 months after surgery.
Left ventricular function
Standard M-mode, two-dimensional and pulsed Doppler
echocardiographic studies (Acuson 128XP; Acuson Inc.,
Mountain View, California – USA) will be performed, be-
fore the surgical operation and 6, 12 months after surgery,
in left lateral recumbent position after a 10 minutes rest-
ing period, according to the reccomandations of the
American Society of Echocardiography [22]. The follow-
ing measurements will be recorded on M-mode tracing:
left ventricular (LV) end-diastolic and end-systolic diame-
ters, left atrial end-systolic diameter, interventricular sep-
tum thickness (IVST), posterior wall thickness. The
relative thickness of the LV wall, with respect to the LV
end-diastolic diameter, will be also calculated. The LV my-
ocardial mass will be calculated using Deveraux's formula
from the M-mode measurements [23]. LV hypertrophy
will be considered when LV myocardial mass values cor-
rected for body surface area (LVMI) is greater than or
equal to 125 g/m2 in males and females, according to the
Penn Convention sex independent criteria. The Doppler
study will provide indexes of left ventricular filling, which
will be derived from the mitral flow velocities curves:
maximal early diastolic flow velocity (E, cm/sec), maxi-
mal late diastolic flow velocity (A, cm/sec) and the E/A ra-
tio (normal value > 1). Finally, ejection fraction (EF%),
that is an index of systolic ventricular function, will be
also calculated.
The sonographer will be blinded to all clinical and meta-
bolic data.
Collagen deposition (UTC)
Experimental and clinical studies have demonstrated the
possibility of non invasively assessing the ultrastructuralBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/19
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properties of tissues by ultrasound. In particular, intersti-
tial collagen, because of its acoustic impedance, has been
proven to be the main determinant for the echo texture
image from the myocardium [24,25], and quantitative
analysis of the ultrasound signals from the myocardium
has demonstrated increased sensitivity for detection of
collagen accumulation [26–28].
Echocardiographic images and simultaneous ECG trac-
ings will be recorded on videotape in S-VHS format. Two
representative subsequent cardiac cycles in each subject
(synus rhythm at the surface electrocardiogram) will be
digitized off-line from the videotape onto a personal com-
puter (Power Machintosh G3 av, 300 MHz, 136 MB RAM,
8 GB hard drive; Apple Computer, Inc., Cupertino, Cali-
fornia – USA) for the subsequent echoreflectivity analysis,
using the built-in video digitizer card operating at 30
frames/sec and 8 bits/pixel on a standard PAL pixel matrix
(640  480 pixels).
In order to obtain a better visualisation of the myocardial
structure, the colour scale will be set at 256 colours (0 =
yellow, 128 = magenta red, 255 = black), re-coding the
original 256 echo grey scale (0 = white, 255 = black). UTC
will be performed by two operators, blinded to all clinical
and metabolic data, using two-dimensional long-axis
end-diastolic echo recorded images. In each patient the re-
gion of ventricular wall for the analysis will be selected by
positioning a square selection tool (5  5 mm) in the mid
portion of interventricular septum, avoiding areas of echo
drop-out. From each selection, according to a previously
described procedure [29], a colour-level histogram repre-
senting the frequency distribution (number of pixels ver-
sus echo intensity) will be derived, using a software
developed in our laboratory. Histograms will be described
in terms of average pixel intensity (mCS) and colour spec-
trum width (broad band, Bb); the latter indicates the
spread of the echoes about the mean distribution and re-
flects the interactions of echoes within the tissue, as a
function of ultrasound velocity and distance between scat-
ters. For each patient we will consider the average of three
consecutive end-diastolic measurements. Collagen con-
tent (derived collagen volume fraction, dCVF%; normal
values up to 2%) will be predicted as a dependent variable
in a regression model using the independent variable Bb
as predictor according to the following formula: dCVF% =
(Bb – 43,4) / 22,67. Bb, in fact, has been proven to corre-
late with the histologically assessed collagen content in a
previous study [29]. To avoid the effects on image texture
caused by the characteristics of the ultrasound image sys-
tem, all mCS values obtained from the interventricular
septum will be normalized for blood echoreflectivity
(black = 255), assessed along the same axis inside the left
ventricle, in each single patient (Figure 1).
Statistical analysis
Data will be analyzed using a computer statistical software
(SPSS – Rel 10; SPSS Inc., Chicago, Ill). All the quantita-
tive variables will be tested for Gaussian distribution with
the Kolmogorov-Smirnov test; all of them that will follow
this distribution will be presented as mean  standard de-
viation.
Differences at baseline in collagen parameters between
IBD patients and controls will be tested for significance
using the analysis of variance with the Bonferroni correc-
tion. The relation between collagen parameters and the es-
timated duration of the disease will be expressed in terms
of regression analysis. The intra-assay variability will be
tested in 10 randomly chosen subjects by repeating all the
collagen determinations in 3 different samples in each
subject. Interobserver and intraobserver reproducibility of
UTC measurements will be evaluated by comparing meas-
urements made by two different observers on the same
day and by the same observer in two different days, re-
spectively. To evaluate changes over time (before and after
surgery) in collagen parameters in each patient, MANCO-
VA for repeated measurements will be used; age and sex
Figure 1
Schematic representation of a 2D long-axis echography of
the heart illustrating the region of analysis (S1) in the mid-
apex interventricular septum from which the measurements
will be taken. Values obtained will be normalized for blood
echoreflectivity assessed along the same axis inside the left
ventricle (S2). LV = Left Ventricle; LA = Left Atrium; AO =
Aorta. S1 and S2 indicate the regions of interest for the ultra-
sonic tissue characterization (myocardium and blood, respec-
tively).BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/19
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will be included as covariates in the analysis. In all cases a
p value less than 0.05 will be considered significant.
Discussion
Till now the link between IBD and cardiovascular diseases
has been reported only in few published cases, but none
of them has focused the attention on the possible in-
creased collagen deposition far from the main target or-
gan. Because increased myocardial collagen deposition is
a recognized marker of pathologic structural remodelling,
at this respect, from this study protocol we expect addi-
tional information about what happens at the heart level
after a long standing history of IBD and to elucidate
wheather or not the surgical option could arrest an evenc-
tual cardiac damage.
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